Supervisory Board
The Prosensa Supervisory board:
-
Daan Ellens - Chairman
Daan Ellens is chairman of the Prosensa supervisory board. He also serves as chairman of the supervisory board of Hybrigenics (F), Zealand Pharma (DK) and Kreatech Biotechnology (NL).
-
Stephen Bunting
Stephen Bunting is the Managing Partner of Abingworth LLP and has over 25 years experience in the venture capital business.
-
Rémi Droller
Rémi joined Kurma in September 2010, he was previously with CDC Innovation from 2000 to 2003 and with AGF Private Equity (now Idinvest Partners) from 2003 to 2010.
-
Peter Goodfellow
Peter Goodfellow joined the supervisory board in 2008. In addition, he serves as a director of the Institute of Cancer Research and as a member of several advisory boards.
-
Martijn Kleijwegt
Martijn Kleijwegt became a member Prosensa’s supervisory board in 2008. He founded Life Sciences Partners in 1998 and has been managing partner of Life Sciences Partners since then.
-
Jim Van heusden
Jim Van heusden is partner venture capital at Gimv, focused on investments in Life Sciences. He currently serves on the board of Ablynx, ActoGenix, Nereus Pharmaceuticals & Pronota.
-
John de Koning - Observer
John de Koning is partner at LSP (Life Sciences Partners). John currently serves on the supervisory boards of Pronota, Skyline Diagnostics, arGEN-X, Merus and Innovative Biosensors.
-
John Shields - Observer
John Shields has 13 years of operational experience in life science companies. He joined Abingworth in 2001 from Cantab Pharmaceuticals where he was Senior Vice-President, Research.
